How Can Rehospitalisations of Patients With Schizophrenia be Avoided? A Comparison Between Different Compliance Programs

August 28, 2014 updated by: Technical University of Munich
Participation in one of the three interventions psychoeducation by professionals, psychoeducation by peer-moderators, or video-education can reduce the rehospitalisation rate of patients with schizophrenia compared to a control group.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

896

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • München, Germany, 81675
        • Klinik und Poliklinik für Psychiatrie und Psychotherapie am Klinikum rechts der Isar der Technischen Universität München

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 67 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Schizophrenia or schizoaffective disorder (ICD-10)
  • Age 18 to 67 years
  • Hospitalised or treated in day care clinic

Exclusion Criteria:

  • More than 12 months of hospitalisation within the last two years
  • Substance-dependency (principal diagnosis)
  • Mental retardation ICD-10 Chapter F70-79
  • Fluency of German language not given

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 2
Psychoeducation by peer-moderators
Experimental: 1
Psychoeducation by professionals
Experimental: 3
Video-education
Placebo Comparator: 4
Control group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Rehospitalisation rate

Secondary Outcome Measures

Outcome Measure
Quality of life
Compliance
Rehospitalisation days
Resulting costs per patient
Knowledge of illness
Attitude towards illness
Satisfaction with treatment
Duration of consultation time
Dealing with mental illness

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Werner Kissling, MD, Technical University of Munich

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2006

Primary Completion (Actual)

December 1, 2011

Study Completion (Actual)

December 1, 2011

Study Registration Dates

First Submitted

August 9, 2007

First Submitted That Met QC Criteria

August 9, 2007

First Posted (Estimate)

August 10, 2007

Study Record Updates

Last Update Posted (Estimate)

August 29, 2014

Last Update Submitted That Met QC Criteria

August 28, 2014

Last Verified

August 1, 2014

More Information

Terms related to this study

Other Study ID Numbers

  • 01GL0509
  • ISRCTN19638644

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Schizophrenia

Clinical Trials on Psychoeducation by peer-moderators

Subscribe